Related references
Note: Only part of the references are listed.Peroxisome proliferator-activated receptor gamma overexpression suppresses proliferation of human colon cancer cells
Tamotsu Tsukahara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Phospholipase D2-Dependent Inhibition of the Nuclear Hormone Receptor PPARγ by Cyclic Phosphatidic Acid
Tamotsu Tsukahara et al.
MOLECULAR CELL (2010)
Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator-activated receptor γ
Tamotsu Tsukahara et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
Voltage-dependent anion channel (VDAC) is involved in apoptosis of cell lines carrying the mitochondrial DNA mutation
Liu Yuqi et al.
BMC MEDICAL GENETICS (2009)
Nuclear Receptor Coregulators in Cancer Biology
Bert W. O'Malley et al.
CANCER RESEARCH (2009)
Peroxisome Proliferator-Activated Receptor gamma Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
Frank Ondrey
CLINICAL CANCER RESEARCH (2009)
Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA
Gang Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
PPAR-γ ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo
I. K. Choi et al.
INVESTIGATIONAL NEW DRUGS (2008)
Proteomic trajectory mapping of biological transformation: Application to developmental mouse retina
Hisao Haniu et al.
PROTEOMICS (2006)
Different residues mediate recognition of 1-O-oleyl-lysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor γ
T Tsukahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Roles of PSF protein and VL30 RNA in reversible gene regulation
X Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
DL Feinstein et al.
BIOCHEMICAL PHARMACOLOGY (2005)
The nuclear receptor superfamily: A Rosetta Stone for physiology
RM Evans
MOLECULAR ENDOCRINOLOGY (2005)
Bax-dependent regulation of Bak by voltage-dependent anion channel 2
D Chandra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor
XS Dong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The PPAR-γ agonist pioglitazone post-transcriptionally induces p21 in PC3 prostate cancer but not in other cell lines
SK Radhakrishnan et al.
CELL CYCLE (2005)
Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: Effects on steroidogenesis and oncogenesis
X Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
VDAC2 inhibits BAK activation and mitochondrial apoptosis
EHY Cheng et al.
SCIENCE (2003)
PTB-associated splicing factor regulates growth factor-stimulated gene expression in mammalian cells
RJ Urban et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Target genes of peroxisome proliferator-activated receptor γ in colorectal cancer cells
RA Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Caspases are reversibly inactivated by hydrogen peroxide
V Borutaite et al.
FEBS LETTERS (2001)
PSF is a novel corepressor that mediates its effect through Sin3A and the DNA binding domain of nuclear hormone receptors
M Mathur et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
H Sato et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
